C B Smith|D M Bowen - JoVE Visualize

Showing results (241-250 of 281) with videos related to

Pageof 29

Sort By:

Chemical Communications (Cambridge, England)|September 21, 2002

The effect of the primary structure of the polypeptide catalyst on the enantioselectivity of the Juliá-Colonna asymmetric epoxidation of enonesP A Bentley, R W Flood, S M Roberts, et al.

Biological Psychiatry|July 1, 1990

Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjectsO G Cameron, C B Smith, M A Lee, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1986

Neuropsychological syndromes in presenile dementia due to cerebral atrophyD Neary, J S Snowden, D M Bowen, et al.

Brain Research|August 14, 1989

Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortemP T Francis, A Poynton, S L Lowe, et al.

Journal of Cardiovascular Pharmacology|September 1, 1986

Sympathetic inhibition with methyldopa in heart failureP C Kirlin, S Das, R Grekin, et al.

Science (New York, N.Y.)|August 17, 1979

Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the ratW J Schwartz, C B Smith, L Davidsen, et al.

Molecular Pharmacology|February 1, 1995

Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytesZ Szallasi, K Kosa, C B Smith, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1991

Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamineD S Goldstein, P C Chang, C B Smith, et al.

The New England Journal of Medicine|July 4, 1985

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatmentP T Francis, A M Palmer, N R Sims, et al.

Annals of the New York Academy of Sciences|September 24, 1993

Neurotransmitters and second messengers in aging and Alzheimer's diseaseP T Francis, M T Webster, I P Chessell, et al.

Pageof 29

Showing results (241-250 of 281) with videos related to

Sort By:

Pageof 29

Chemical Communications (Cambridge, England)|September 21, 2002

The effect of the primary structure of the polypeptide catalyst on the enantioselectivity of the Juliá-Colonna asymmetric epoxidation of enonesP A Bentley, R W Flood, S M Roberts, et al.

Biological Psychiatry|July 1, 1990

Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjectsO G Cameron, C B Smith, M A Lee, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1986

Neuropsychological syndromes in presenile dementia due to cerebral atrophyD Neary, J S Snowden, D M Bowen, et al.

Brain Research|August 14, 1989

Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortemP T Francis, A Poynton, S L Lowe, et al.

Journal of Cardiovascular Pharmacology|September 1, 1986

Sympathetic inhibition with methyldopa in heart failureP C Kirlin, S Das, R Grekin, et al.

Science (New York, N.Y.)|August 17, 1979

Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the ratW J Schwartz, C B Smith, L Davidsen, et al.

Molecular Pharmacology|February 1, 1995

Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytesZ Szallasi, K Kosa, C B Smith, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1991

Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamineD S Goldstein, P C Chang, C B Smith, et al.

The New England Journal of Medicine|July 4, 1985

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatmentP T Francis, A M Palmer, N R Sims, et al.

Annals of the New York Academy of Sciences|September 24, 1993

Neurotransmitters and second messengers in aging and Alzheimer's diseaseP T Francis, M T Webster, I P Chessell, et al.

Pageof 29